GlassScriptPhysician profile
Brian George Burnikel
NPI 1548372113
$4,876.83
in general payments reported to CMS, 2019-2025
9 companies · $550 in 2025
The $550 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $409 · 2021: $664 · 2022: $106 · 2023: $2,592 · 2024: $204 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075 · Travel and Lodging: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.40 |
| Travel and Lodging | $1,270.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,197.19 | 2019-2025 | Journey, Polarstem, Ri Hip Navigation |
| Biom'Up France Sas | $146.72 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $123.46 | 2025 | |
| Stryker Corporation | $115.37 | 2025 | 1788, Mako |
| Depuy Synthes Sales INC. | $114.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $96.45 | 2019 | |
| Avanos Medical | $39.93 | 2021 | |
| Abbott Laboratories | $24.21 | 2021 | |
| Pacira Therapeutics, INC. | $19.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Burnikel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.